Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 1

Cardiovascular morbidity and the use of inhaled bronchodilators

Authors Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas Anthonisen

Published Date March 2008 Volume 2008:3(1) Pages 163—169

DOI http://dx.doi.org/10.2147/COPD.S1516

Published 18 March 2008

Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas Anthonisen

Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

Abstract: We used the Manitoba Health database to examine the relationship between use of inhaled respiratory drugs in people with chronic obstructive respiratory diseases and cardiovascular hospitalizations from 1996 through 2000. The drugs examined were beta agonists [BA], ipratropium bromide IB, and inhaled steroids (ICS). End points were first hospitalizations for supraventricular tachycardia, myocardial infarction, heart failure or stroke. A nested case control analysis was employed comparing people with and without cardiovascular events. Cases and controls were matched for gender and age, and conditional logistic regression was used in multivariate analysis considering other respiratory drugs, respiratory diagnosis and visit frequency, non-respiratory, non-cardiac comorbidities, and receipt of drugs for cardiovascular disease. In univariate analyses, BA, IB and ICS were all associated with hospitalizations for cardiovascular disease, but in multivariate analyses ICS did not increase risk while both BA and IB did. There were interactions between respiratory and cardiac drugs receipt in that bronchodilator associated risks were higher in people not taking cardiac drugs; this was especially true for stroke. There were strong interactions with specific cardiac drugs; for example, both BA and IB substantially increased the risk of supraventricular tachycardia in patients not anti-arryhthmic agents, but not in the presence of such agents. We conclude that bronchodilator therapy for chronic obstructive diseases is associated with increased cardiovascular risk, especially in patients without previous cardiovascular diagnoses, and that this is unlikely due to the severity of the respiratory disease, since risk was not increased with ICS.

Keywords: bronchodilator therapy, inhaled corticosteroids, nested case control study

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway

Zhao Y, Hu JY, Li RG, Song J, Kang YJ, Liu S, Zhang DW

OncoTargets and Therapy 2015, 8:1553-1559

Published Date: 22 June 2015

Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

Capolla S, Garrovo C, Zorzet S, Lorenzon A, Rampazzo E, Spretz R, Pozzato G, Núñez L, Tripodo C, Macor P, Biffi S

International Journal of Nanomedicine 2015, 10:4099-4109

Published Date: 22 June 2015

In situ precipitation: a novel approach for preparation of iron-oxide magnetoliposomes

Xia S, Li P, Chen Q, Armah M, Ying X, Wu J, Lai J

International Journal of Nanomedicine 2014, 9:2607-2617

Published Date: 23 May 2014

Bioavailability of nanoemulsified conjugated linoleic acid for an antiobesity effect

Kim D, Park JH, Kweon DJ, Han GD

International Journal of Nanomedicine 2013, 8:451-459

Published Date: 4 February 2013

Effect of molecular weight of polyethyleneimine on loading of CpG oligodeoxynucleotides onto flake-shell silica nanoparticles for enhanced TLR9-mediated induction of interferon-α

Manoharan Y, Ji Q, Yamazaki T, Chinnathambi S, Chen S, Ganesan S, Hill JP, Ariga K, Hanagata N

International Journal of Nanomedicine 2012, 7:3625-3635

Published Date: 16 July 2012

Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians

Gregory D Salinas, James C Williamson, Ravi Kalhan, et al

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:171-179

Published Date: 28 February 2011

Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study

Robert M Shavelle, David R Paculdo, Scott J Kush, David M Mannino, David J Strauss

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:137-148

Published Date: 18 March 2009

Reticular basement membrane in asthma and COPD: Similar thickness, yet different composition

Jeroen JW Liesker, Nick H Ten Hacken, Mieke Zeinstra-Smith, Steven R Rutgers, Dirkje S Postma, et al.

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:127-135

Published Date: 26 February 2009

Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care

Carl Llor, Silvia Hernández, Anna Ribas, Carmen Álvarez, Josep Maria Cots, et al

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:45-53

Published Date: 15 October 2008